Validation of the Methotrexate‐First Strategy in Patients With Early, Poor‐Prognosis Rheumatoid Arthritis: Results From a Two‐Year Randomized, Double‐Blind Trial

Publisher: John Wiley & Sons Inc

E-ISSN: 1529-0131|65|8|1985-1994

ISSN: 0004-3591

Source: Arthritis & Rheumatism, Vol.65, Iss.8, 2013-08, pp. : 1985-1994

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content